Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) S.A.E. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was EGP 1,922.35 million compared to EGP 1,483.95 million a year ago. Net income was EGP 244.86 million compared to EGP 245.68 million a year ago.

Basic earnings per share from continuing operations was EGP 0.1499 compared to EGP 0.1552 a year ago. Diluted earnings per share from continuing operations was EGP 0.1489 compared to EGP 0.1544 a year ago.